With the world focused on COVID-19 vaccines, a breakthrough has been made in the fight against another disease.
The W.H.O. has approved a malaria vaccine for widespread use among children in Africa.
It follows decades of development and successful trials in Ghana, Kenya and Malawi.
Could it help eradicate the disease? And will it be affordable for those who need it most?
Presenter: Kamahl Santamaria
Guests:
Akpaka Kalu - W.H.O. Regional Adviser for Tropical and Vector borne Diseases
Helen Rees - Board Member, Gavi, the Vaccine Alliance
Abdhalah Ziraba - Research Scientist, African Population and Health Research Center
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#WHO #MalariaVaccine #Mosquirix
The W.H.O. has approved a malaria vaccine for widespread use among children in Africa.
It follows decades of development and successful trials in Ghana, Kenya and Malawi.
Could it help eradicate the disease? And will it be affordable for those who need it most?
Presenter: Kamahl Santamaria
Guests:
Akpaka Kalu - W.H.O. Regional Adviser for Tropical and Vector borne Diseases
Helen Rees - Board Member, Gavi, the Vaccine Alliance
Abdhalah Ziraba - Research Scientist, African Population and Health Research Center
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#WHO #MalariaVaccine #Mosquirix
- Category
- World
- Tags
- Africa latest news, Al Jazeera, COVAX
Sign in or sign up to post comments.
Be the first to comment